Reto A. Gadient

Camino Pharma LLC is a start-up company based in the United States that focuses on discovering and developing first-in-class therapies for cancer and CNS disorders. The American company targets signaling proteins based on emerging biological concepts and discovers novel mechanisms for modulating these targets with small molecule drugs. Camino Pharma's leadership team has proven expertise in relevant target biology and extensive experience in drug discovery and development. The private company's goal is to discover and develop novel, first-in-class treatments for the most aggressive forms of cancer and poorly addressed psychiatric disorders, including substance use and major depression. Camino Pharma's innovative technology platform allows for exploiting inadequately served targets that require a highly adaptive and specialized approach to drug discovery.

BrainCells Inc. discovers and develops drugs. The company was founded by Fred H. Gage and Harry F. Hixson, Jr. in 2003 and is headquartered in San Diego, CA.